Hemophilia Blood Clotting

806 Words4 Pages
Hemophilia is a genetic disorder that slows the process of blood clotting. The majority of sufferers bleed extensively after injury or medical operation. In serious cases, there is spontaneous bleeding in the joints. “Milder forms of hemophilia do not necessarily involve spontaneous bleeding, and the condition may not become apparent until abnormal bleeding occurs following surgery or a serious injury.” (Genetics Home Reference) Males are more prone to Hemophilia. Two main types are Hemophilia A and Hemophilia B. Someone with Hemophilia A lacks clotting factor 8. Whilst people with Hemophilia B lack clotting factor 9. If one blood clotting factor is eliminated, the process of clotting falls apart. It can be compared with a chain reaction.…show more content…
Fathers are unable to pass the gene to their son. Boys have a higher chance of contracting the disease than girls. Boys receive the gene from their mothers. Most women who have the gene are carriers, they may experience slight symptoms though. In this age, it is possible to discover if the fetus has the gene for hemophilia, though the tests are extremely risky. Hemophilia can be quickly diagnosed from an early age, usually between 9 months and 2 years. Diagnosis can be after birth, with a blood test using blood from the umbilical cord. If the family has a history of Hemophilia, then this may be a good time to test. Before pregnancy, a genetic test can determine whether or not there is a possibility of passing on the gene, granted that there is history of Hemophilia in the family. There is no cure for hemophilia that we know of, but hemophilia is not a crippling disease. Someone with hemophilia can live a normal life. There are many treatments for hemophilia, different ones are used for different severity levels of hemophilia. For mild hemophilia A sufferers, they are injected with DDAVP which is a hormone that stimulates the missing blood clotting factors. For severe Hemophilia B and A, infusions and sometimes blood transplants are used. For the rarer Hemophilia C, in the US, plasma infusions are used, while in Europe, patients are supplied with clotting factor 11. Physical therapy is also offered to some
Get Access